← Leaderboards
Paolo Lusso
Niaid Extramural Activities
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Niaid Extramural Activities
Same institution · by research overlap
Others in their field
Top investigators on “Hiv-1”
- Barton F Haynes · Duke University$476,288,740
- Lawrence Corey · Fred Hutchinson Cancer Center$445,419,385
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$294,186,693
- Constance Ann Benson · University Of California, San Diego$272,046,180
- Peter B. Gilbert · Fred Hutchinson Cancer Center$173,010,936
- Dan H. Barouch · Fred Hutchinson Cancer Center$166,542,502
Research focus
Hiv-1In VivoInfectionMacacaDesignMediatingGlycoproteinsProteinsReceptorHiv InfectionsSurfaceT-LymphocyteCd4 Positive T LymphocytesAntibodiesCellsVaccinesDosePreventVirionBindingMacaca MulattaPreventionProductionCytokine
Grant awards (42)
Structure-Function Studies of the HIV-1 Envelope Glycoproteins and Development of VLP-forming vaccine strategies for HIV-1$1,373,021
ZIA · FY2025 · AI · contact PI
Role of IL-7 as a Key Immune Response Primer$1,035,789
ZIA · FY2025 · AI · contact PI
Optimization and Pre-Clinical Evaluation of New Strategies for HIV-1 Prevention and Treatment$621,528
ZIA · FY2025 · AI · contact PI
Structure-Function Studies of the HIV-1 Envelope Glycoproteins and Development of a VLP-forming mRNA vaccine for HIV-1$1,410,429
ZIA · FY2024 · AI · contact PI
Role of IL-7 in Immune Defense against HIV-1 and Other Infectious Pathogens$705,216
ZIA · FY2024 · AI · contact PI
Pathogenesis studies on COVID-19 and development of a VLP-forming mRNA vaccine against SARS-CoV2$133,896
ZIA · FY2024 · AI · contact PI
Structure-Function Studies of the HIV-1 Envelope Glycoproteins and Development of a VLP-forming mRNA vaccine for HIV-1$1,829,883
ZIA · FY2023 · AI · contact PI
Role of IL-7 and Integrin alpha4beta7 in Human Immunodeficiency Virus Infection$724,168
ZIA · FY2023 · AI · contact PI
Pathogenesis studies on COVID-19 and development of a VLP-forming mRNA vaccine against SARS-CoV2$101,616
ZIA · FY2023 · AI · contact PI
Structure-Function Studies of the HIV-1 Envelope Glycoproteins$1,549,551
ZIA · FY2022 · AI · contact PI
Role of IL-7 and Integrin alpha4beta7 in Human Immunodeficiency Virus Infection$763,212
ZIA · FY2022 · AI · contact PI
Design and validation of VLP/mRNA-based vaccine strategies against SARS-CoV2$160,169
ZIA · FY2022 · AI · contact PI
Structure-Function Studies of the HIV-1 Envelope Glycoproteins$1,665,552
ZIA · FY2021 · AI · contact PI
Role of IL-7 and Integrin alpha4beta7 in Human Immunodeficiency Virus Infection$497,504
ZIA · FY2021 · AI · contact PI
Design and validation of VLP/mRNA-based vaccine strategies against SARS-CoV2$121,121
ZIA · FY2021 · AI · contact PI
Structure-Function Studies of the HIV-1 Envelope Glycoproteins$1,847,653
ZIA · FY2020 · AI · contact PI
Role of IL-7 and Integrin alpha4beta7 in Human Immunodeficiency Virus Infection$615,886
ZIA · FY2020 · AI · contact PI
Design and validation of VLP/mRNA-based vaccine strategies against SARS-CoV2$67,461
ZIA · FY2020 · AI · contact PI
Structure-Function Studies of the HIV-1 Envelope Glycoproteins$1,798,354
ZIA · FY2019 · AI · contact PI
Role of IL-7 and Integrin alpha4beta7 in Human Immunodeficiency Virus Infection$599,453
ZIA · FY2019 · AI · contact PI
Structure-Function Studies of the HIV-1 Envelope Glycoproteins$1,961,140
ZIA · FY2018 · AI · contact PI
Role of IL-7 and Integrin alpha4beta7 in Human Immunodeficiency Virus Infection$525,340
ZIA · FY2018 · AI · contact PI
Structure-Function Studies of the HIV-1 Envelope Glycoproteins$1,238,374
ZIA · FY2017 · AI · contact PI
Natural Antiviral Factors Expressed by CD8+T Cells and Other Immune System Cells$530,732
ZIA · FY2017 · AI · contact PI
Structure-Function Studies of the HIV-1 Envelope Glycoproteins$976,050
ZIA · FY2016 · AI · contact PI
Natural Antiviral Factors Expressed by CD8+T Cells and Other Immune System Cells$244,013
ZIA · FY2016 · AI · contact PI
Structure-Function Studies of the HIV-1 Envelope Glycoproteins$691,592
ZIA · FY2015 · AI · contact PI
Role of IL-7 in Human Immunodeficiency Virus Infection$230,531
ZIA · FY2015 · AI · contact PI
Natural Antiviral Factors Expressed by CD8+T Cells and Other Immune System Cells$230,531
ZIA · FY2015 · AI · contact PI
Structure-Function Studies of the HIV-1 Envelope Glycoproteins$486,012
ZIA · FY2014 · AI · contact PI
Role of IL-7 in Human Immunodeficiency Virus Infection$291,607
ZIA · FY2014 · AI · contact PI
Natural Antiviral Factors Expressed by CD8+T Cells and Other Immune System Cells$194,405
ZIA · FY2014 · AI · contact PI
Natural Antiviral Factors Expressed by CD8+T Cells and Other Immune System Cells$675,330
ZIA · FY2013 · AI · contact PI
Role of IL-7 in Human Immunodeficiency Virus Infection$289,427
ZIA · FY2013 · AI · contact PI
Natural Antiviral Factors Expressed by CD8+T Cells and Other Immune System Cells$538,572
ZIA · FY2012 · AI · contact PI
Role of IL-7 in Human Immunodeficiency Virus Infection$359,048
ZIA · FY2012 · AI · contact PI
Role of IL-7 in Human Immunodeficiency Virus Infection$876,466
ZIA · FY2011 · AI · contact PI
Role of IL-7 in Human Immunodeficiency Virus Infection$717,033
ZIA · FY2010 · AI · contact PI
Immunomodulatory Effects of IL-7 in Primate Immunodeficiency Virus Infections$841,055
ZIA · FY2009 · AI · contact PI
Protective Effect of IL-7 against Spontaneous T-Cell Apoptosis$769,603
Z01 · FY2008 · AI · contact PI
Protective Effect of IL-7 against Spontaneous T-Cell Apoptosis$819,811
Z01 · FY2007 · AI · contact PI
Protective Effect of IL-7 against Spontaneous T-Cell Apo$0
Z01 · FY2006 · AI · contact PI